Corticosteroid-sparing options in the treatment of childhood asthma

Drugs

Volumn 59, Issue SUPPL. 1, 2000, Pages 15-22

  Helms, Peter J ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; ANTIHISTAMINIC AGENT; ANTIINFLAMMATORY AGENT; BECLOMETASONE DIPROPIONATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CETIRIZINE; COLLAGEN; CORTICOSTEROID; CROMOGLYCATE DISODIUM; DEOXYPYRIDINOLINE; IMMUNOGLOBULIN E; KETOTIFEN; LEUKOTRIENE DERIVATIVE; MONTELUKAST; PYRIDINIUM DERIVATIVE; PYRIDINOLINE; SALMETEROL; THEOPHYLLINE; ZAFIRLUKAST;

ALLERGIC ASTHMA; ALTERNATIVE MEDICINE; ANTIINFLAMMATORY ACTIVITY; BONE MARROW DISEASE; CHILD; COST EFFECTIVENESS ANALYSIS; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; EARLY DIAGNOSIS; GROWTH RETARDATION; HUMAN; INFANT; REVIEW; TREATMENT OUTCOME;

EID: 0034070121     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-200059001-00003     Document Type: Review

References (75)

1. Ninan TK, Russell G. Respiratory symptoms and atopy in Aberdeen schoolchildren: evidence from two surveys 25 years apart. BMJ 1992; 304: 873-5
2. Burr ML, Butland BK, King S, et al. Changes in asthma prevalence: two surveys 15 years apart. Arch Dis Child 1989; 64: 1452-6
3. Robertson CF, Heycock E, Bishop J, et al. Prevalence of asthma in Melbourne schoolchildren: changes over 26 years. BMJ 1991; 302: 1116-8
4. Warner JO, Gotz M, Landau LI, et al. Management of asthma: a consensus statement. Arch Dis Child 1989; 64: 1065-79
5. Wilson NM. Wheezy bronchitis revisited. Arch Dis Child 1989; 64: 1194-9
6. Christie G, Helms P. Childhood asthma: what is it and where is it going? Thorax 1995; 50: 1027-30
7. Martinez FD, Wright AL, Taussig LM, et al. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med 1995; 332: 133-8
8. Brooke AM, Lambert PC, Burton PR, et al. The natural history of respiratory symptoms in preschool children. Am J Respir Crit Care Med 1995; 152 (6 Pt 1): 1872-8
9. Silverman M. Out of the mouths of babes and sucklings: lessons from early childhood asthma. Thorax 1993; 48 (12): 1200-4
10. Martinez FD, Morgan WJ, Wright AL, et al. Diminished lung function as a predisposing factor for wheezing respiratory illness in infants. N Engl J Med 1988; 319: 1112-7
11. Wang X, Wypij D, Gold DR, et al. A longitudinal study of the effects of parental smoking on pulmonary function in children 6-18 years. Am J Respir Crit Care Med 1994; 149: 1420-5
12. Pattemore PK, Asher MI, Harrison AC, et al. The interrelationship among bronchial hyperresponsiveness, the diagnosis of asthma, and asthma symptoms. Am Rev Respir Dis 1990; 142: 549-54
13. Peat JK, Britton WJ, Salome CM, et al. Bronchial hyperresponsiveness in two populations of Australian schoolchildren. 11. Relative importance of associated factors. Clin Allergy 1987; 17: 283-90
14. Burrows B, Marinez FD, Halonen M, et al. Association of asthma with serum IgE levels and skin-test reactivity to allergens. N Engl J Med 1989; 320 (5): 271-7
15. Kelly WJ, Hudson I, Phelan PD, et al. Atopy in subjects with asthma followed to the age of 28 years. J Allergy Clin Immunol 1990; 85 (3): 548-57
16. Martin AJ, Landau LI, Phelan PD. Asthma from childhood at age 21: the patient and his disease. BMJ 1982; 284: 380-2
17. Roorda RJ, Gerritsen J, Van Aalderen WMC, et al. Risk factors for the persistence of respiratory symptoms in childhood asthma. Am Rev Respir Dis 1993; 148 (6 Pt 1): 1490-5
18. Gottlieb DJ, Sparrow D, O'Connor GT, et al. Skin test reactivity to common aeroallergens and decline in lung function: the Normative Aging Study. Am J Respir Crit Care Med 1996; 153: 561-6
19. Sporik R, Holgate ST, Cogswell JJ. Natural history of asthma in childhood - a birth cohort study. Arch Dis Child 1991; 66: 1050-3
20. Donahue JG, Weiss ST, Livingston JM, et al. Inhaled steroids and the risk of hospitalization for asthma. JAMA 1997; 277: 887-91
21. Wennergren G, Kristjansson S, Strannegard IL. Decrease in hospitalization for treatment of childhood asthma with increased use of antiinflammatory treatment, despite an increase in the prevalence of asthma. J Allergy Clin Immunol 1996; 97: 742-8
22. Paterson NAM, Peal JK, Mellis CM, et al. Accuracy of asthma treatment in schoolchildren in NSW, Australia. Eur Respir J 1997; 10: 658-64
23. British Asthma Guidelines coordinating committee. The British guidelines on asthma management 1995 review and position statement. Thorax 1997; 52: S1-21
24. International consensus report on diagnosis and treatment of asthma. National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD. Publication no. 92-3091, March 1992. Eur Respir J 1992; 5: 601-41
25. National Heart, Lung, and Blood Institute and World Health Organization. Global Initiative for Asthma. Global strategy lor asthma management and prevention. NIH Publication no. 95-3659. Bethesda, MD: National Institutes of Health, 1995: 1-48
26. National Heart, Lung, and Blood Institute. National Asthma Education and Prevention Program. Hxpert Panel Report 2: guidelines for the diagnosis and management ofasthma. NIH Publication no. 97-4051. Bethesda, MD: National Institutes of Health, 1997: 1-50
27. Silverman M, Wilson N. Asthma - time for a change of name? Arch Dis Child 1997; 77: 62-5
28. Clifford RD, Howell JB, Radford M, et al. Associations between respiratory symptoms, bronchial response to methacholine, and atopy in two age groups of schoolchildren. Arch Dis Child 1989; 64: 1133-9
29. De Gooijer A, Brand PLP, Gerritsen J, et al. Changes in respiratory symptoms and airway hyperresponsiveness after 27 years in a population-based sample of school children. Eur Respir J 1993; 6: 848-54
30. Reijonen TM, Korppi M. One-year follow-up of young children hospitalized for wheezing: the influence of early anti-inflammatory therapy and risk factors for subsequent wheezing and asthma. Pediatr Pulmonol 1998; 26: 113-9
31. Agertoft L, Pedersen S. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med 1994; 88: 373-81
32. Baxter-Jones ADG, Helms PJ. Effect of early introduction of inhaled steroids in wheeling children presenting in primary care. Eur Respir J 1999; 14: S30-280
33. Doull IJM, Lampe FC, Smith S, et al. Effect of inhaled corticosteroids on episodes of wheezing associated with viral infection in school age children: randomised double blind placebo controlled trial. BMJ 1997; 315: 858-62
34. Kamada AK, Parks DP, Szefler SJ. Inhaled glucocorticoid therapy in children: how much is safe? Pediatr Pulmonol 1992; 12: 71-2
35. Cade A, Butler GE, Morrison JF, et al. High-dose inhaled steroids in asthmatic children. Lancet 1996; 348: 819
36. Doull IJM, Freezer NJ, Holgate ST. Growth of prepubertal children with mild asthma treated with inhaled beclomethasone dipropionate. Am J Respir Crit Care Med 1995; 151: 1715-9
37. Ninan TK, Russell G. Asthma, inhaled corticosteroid treatment, and growth. Arch Dis Child 1992; 67: 703-5
38. Saha MT, Laippala P, Lenko HL. Growth of asthmatic children is slower during than before treatment with inhaled glucocorticoids. Acta Paediatr 1997; 86: 138-42
39. Phillip K. Integrated plasma cortisol concentration in children with asthma receiving long-term inhaled corticosteroids. Pediatr Pulmonol 1992; 12: 84-9
40. Tabachnik E, Zadik Z. Diurnal cortisol secretion during therapy with inhaled beclomethasonc dipropionate in children with asthma. J Pediatr 1991; 118: 294-7
41. Wolthers OD, Pedersen S. Measures of systemic activity of inhaled glucocorticosteroids in children: a comparison of urine cortisol excretion and knemometry. Respir Med 1995; 89: 347-9
42. Wolthers OD, Pedersen S. Short-term growth during treatment with inhaled fluticasone propionate and beclomethasone diproprionate. Arch Dis Child 1993; 68: 673-6
43. MacKenzie CA, Wales JKH, Crowley S, et al. Growth of asthmatic children. BMJ 1991; 303: 416
44. Tinkelman DG, Reed CE, Nelson HS, et al. Aerosol beclomethasone dipropionate compared with theophylline as primary treatment of chronic, mild to moderately severe asthma in children. Pediatrics 1993; 92: 64-77
45. Russell G, Eastell R, MacKenzie C, et al. Childhood asthma and growth - a review of the literature. Respir Med 1994; 88: 31-7
46. Robins SP, Black D, Patterson CR, et al. Evaluation of urinary hydroxypyridinium crosslink measurements as resorption markers in metabolic bone diseases. Eur J Clin Invest 1991; 21: 310-5
47. Robins SP. Pyridinium crosslink as markers of bone resorption. Lancet 1992; 340: 278-9
48. Doull I, Freezer N, Holgate S. Osteocalcin, growth, and inhaled corticosteroids: a prospective study. Arch Dis Child 1996; 74: 497-501
49. Crowley S, Trivedi P, Risteli E, et al. Collagen metabolism and growth in prepubertal children with asthma treated with inhaled steroids. J Pediatr 1998; 132: 409-13
50. Jonsson J, Bousquet J, Jones PW, et al. Treating asthma: health economic aspects. Eur Respir Rev 1995; 5 (30): 270-96
51. Wisniewski AF, Lewis SA, Green DJ, et al. Cross sectional investigation of the effects of inhaled corticosleroids on bone density and bone metabolism in patients with asthma. Thorax 1997; 52: 853-60
52. Packe GE, Douglas JG, McDonald AF, et al. Bone density in asthmatic patients taking high dose inhaled beclomethasone dipropionate and intermittent systemic corticosteroids. Thorax 1992; 47: 414-7
53. Agertoft L, Pedersen S. Bone mineral density in children with asthma receiving long-term treatment with inhaled budesonide. Am J Respir Crit Care Med 1998; 157: 178-83
54. Crowley S, Trivedi P, Risteli L, et al. Collagen metabolism and growth in prepubertal children with asthma treated with inhaled steroids. J Pediatr 1998; 132: 409-13
55. Greening AP, Ind PW, Northfield M, et al. Added salmeterol versus higher dose corticosteroid in asthma patients with symptoms on existing inhaled cortieosteroids. Lancet 1994; 344: 219-24
56. Woolcock A, Lundback B, Ringdal N, et al. Comparison of addition of salmeterol to inhaled steroid with doubling of inhaled steroids. Am Respir Crit Care Med 1996; 153: 1481-8
57. Verberne AAPH, Frost C, Duiverman EJ, et al. Addition of salmeterol versus doubling the dose of beclomethasone in children with asthma. Am J Respir Crit Care Med 1998; 158: 213-9
58. Kimata H, Yoshida A, Ishioka C, et al. Disodium cromoglycate (DSCG) selectively inhibits IgE production and enhances IgG4 production by human B cell in vitro. Clin Exp Immunol 1991; 84 (3): 395-9
59. Iikura Y, Naspitz CK, Mikawa H, et al. Prevention of asthma by ketotifen in infants wilh atopic dermatitis. Ann Allergy 1992; 68: 233-6
60. Bustos GJ, Bustos D, Romero O. Prevention of asthma with ketotifen in preasthmatic children: a three-year follow-up study. Clin Exp Allergy 1995; 25: 568-73
61. Tasche MJ, van dor Wouden JC, Uijen JH, et al. Randomised placebo-controlled trial of inhaled sodium cromoglycate in 1-4-year-old children with moderate asthma. Lancet 1997; 350: 1060-4
62. ETAC Study Group. Allergic factors associated wilh the development of asthma and the influence of cetirizine in a double-blind, randomised, placebo-controlled trial: first results of ETAC. Pediatr Allergy Immunol 1998; 9: 116-24
63. Ward AJM, McKenniff M, Evans JM, et al. Theophylline: an immunomodulatory role in asthma. Am Rev Respir Dis 1993; 147: 518-23
64. Sullivan O, Bekir S, Jaffar Z, et al. Anti-inflammatory effects of low dose oral theophylline in atopic asthma. Lancet 1994; 343: 1006-8
65. Warner JO, Naspitz CK. Third International Pediatric Consensus Statement on the management of childhood asthma. International Pediatric Asthma Consensus Group. Pediatr Pulmonol 1998; 25: 1-17
66. Balfour-Lynn IM, Vulman HB, Wellings R, et al. Tumour necrosis factor-alpha and leukotriene E4 production in wheezy infants. Clin Exp Allergy 1994; 24: 121-6
67. Volovitz B, Faden H, Ogra PL. Release of leukotriene C4 in respiratory tract during acute viral infection. J Pediatr 1988; 112 (2): 218-22
68. Knorr B, Matz J, Bernstein JA, et al. Montelukast for chronic asthma in 6 to 14 year old children. JAMA 1998; 279: 1181-6
69. Lofdahl CG, Reiss TF, Leff JA, et al. Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist Montelukast on tapering inhaled cortieosteroids in asthmatic patients. BMJ 1999; 319: 87-90
70. Kemp JP, Dockhorn RJ, Shapiro GG, et al. Montelukast once daily inhibits exercise-induced bronchoconstriction in 6-to 14-year-old children with asthma. J Pediatr 1998; 133: 424-8
71. Arshad SH, Matthews S, Gant C, et al. Effect of allergen avoidance on development of allergic disorders in infancy. Lancet 1992; 339: 1493-7
72. Custovic A, Simpson A, Chapman MD, et al. Allergen avoidance in the treatment of asthma and atopic disorders. Thorax 1998; 53: 63-72
73. Gotzsche PC, Hammarquist C, Burr M. House dust mite control measures in the management of asthma: meta-analysis. BMJ 1998; 317: 1105-10
74. Walsh LJ, Wong CA, Cooper S, et al. Morbidity from asthma in relation to regular treatment: a community based study. Thorax 1999; 54: 296-300
75. Kelloway JS, Wyatt RA, Aldis SA. Comparison of patients' compliance with prescribed oral and inhaled asthma medications. Arch Intern Med 1994; 154: 1349-52